Endocrine

, Volume 45, Issue 2, pp 230–235 | Cite as

The prevalence of thyroid nodules and its relationship with metabolic parameters in a Chinese community-based population aged over 40 years

  • Hongwei Guo
  • Min Sun
  • Wei He
  • Huanhuan Chen
  • Wen Li
  • Jinmei Tang
  • Wei Tang
  • Jieli Lu
  • Yufang Bi
  • Guang Ning
  • Tao Yang
  • Yu Duan
Original Article

Abstract

To investigate the prevalence of thyroid nodules (TN) among a community population aged >40 years and to explore the association between TN and its metabolic risk factors. Data from 9,533 adults aged over 40 years who participated in the epidemiological investigation of thyroid nodules in a Chinese community-based population from June to December 2011 were included in the analyses. We compared the levels of metabolic indices between the TN group and healthy controls. The prevalence of TN was 46.6 % (39.7 %, men; 50.3 %, women) and it increased significantly with increasing age (P < 0.001). It was significantly higher in the group with hypertension than in that with normotension (P < 0.001) and was 43.0 % in the normal blood glucose group, 49.4 % in the prediabetes group, and 50.9 % in the diabetes group (P < 0.001). Logistic regression analysis indicated that hypertension [odds ratio (OR) = 1.121 (1.025–1.225)] as well as prediabetes and diabetes [OR = 1.130 (1.036–1.233)] were all independent risk factors for TN after adjustment for sex, age, body mass index, blood lipid levels, smoking status, and alcohol consumption. The elderly population had a high prevalence of TN. Hypertension as well as prediabetes and diabetes might be independent risk factors for TN.

Keywords

Thyroid nodules Metabolic parameters Hypertension Prediabetes Diabetes 

Notes

Acknowledgments

This study was supported by the Natural Science Foundation of China (NSFC 81170726), Key Medical Talents from Jiangsu Provincial Health Bureau of China (Duanyu 2011), the Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU (20110312), and the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. We are grateful to all the participants and the medical staff in the study.

Conflict of interest

The authors declare that there are no conflicts of interest.

References

  1. 1.
    S.B. Park, H.C. Choi, N.S. Joo, The relation of thyroid function to components of the metabolic syndrome in Korean men and women. J. Korean Med. Sci. 26(4), 540–545 (2011). doi: 10.3346/jkms.2011.26.4.540 PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    A. Roos, S.J. Bakker, T.P. Links, R.O. Gans, B.H. Wolffenbuttel, Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J. Clin. Endocrinol. Metab. 92(2), 491–496 (2007)PubMedCrossRefGoogle Scholar
  3. 3.
    A.C. Waring, N. Rodondi, S. Harrison, A.M. Kanaya, E.M. Simonsick, I. Miljkovic, S. Satterfield, A.B. Newman, D.C. Bauer, Thyroid function and prevalent and incident metabolic syndrome in older adults: the Health, Ageing and Body Composition Study. Clin. Endocrinol. (Oxf) 76(6), 911–918 (2012). doi: 10.1111/j.1365-2265.2011.04328.x CrossRefGoogle Scholar
  4. 4.
    J. Jin, R. Machekano, C.R. McHenry, The utility of preoperative serum thyroid-stimulating hormone level for predicting malignant nodular thyroid disease. Am. J. Surg. 199(3), 294–297 (2010). discussion 298PubMedCrossRefGoogle Scholar
  5. 5.
    R. Sari, M.K. Balci, H. Altunbas, U. Karayalcin, The effect of body weight and weight loss on thyroid volume and function in obese women. Clin. Endocrinol. (Oxf) 59(2), 258–262 (2003)CrossRefGoogle Scholar
  6. 6.
    M.A. Michalaki, A.G. Vagenakis, A.S. Leonardou, M.N. Argentou, I.G. Habeos, M.G. Makri, A.I. Psyrogiannis, F.E. Kalfarentzos, V.E. Kyriazopoulou, Thyroid function in humans with morbid obesity. Thyroid 16(1), 73–78 (2006). doi: 10.1089/thy.2006.16.73 PubMedCrossRefGoogle Scholar
  7. 7.
    S. Ayturk, A. Gursoy, A. Kut, C. Anil, A. Nar, N.B. Tutuncu, Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area. Eur. J. Endocrinol. 161(4), 599–605 (2009)PubMedCrossRefGoogle Scholar
  8. 8.
    J. Rezzonico, M. Rezzonico, E. Pusiol, F. Pitoia, H. Niepomniszcze, Introducing the thyroid gland as another victim of the insulin resistance syndrome. Thyroid 18(4), 461–464 (2008). doi: 10.1089/thy.2007.0223 PubMedCrossRefGoogle Scholar
  9. 9.
    J. Brunn, U. Block, G. Ruf, I. Bos, W.P. Kunze, P.C. Scriba, Volumetric analysis of thyroid lobes by real-time ultrasound (author’s transl). Dtsch. Med. Wochenschr. 106(41), 1338–1340 (1981). doi: 10.1055/s-2008-1070506 PubMedCrossRefGoogle Scholar
  10. 10.
    D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, S.J. Mandel, E.L. Mazzaferri, B. McIver, F. Pacini, M. Schlumberger, S.I. Sherman, D.L. Steward, R.M. Tuttle, Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19(11), 1167–1214 (2009). doi: 10.1089/thy.2009.0110 PubMedCrossRefGoogle Scholar
  11. 11.
    World Health Organization, Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus WHO/NCD/NCS/99, vol. 2nd edn. (World Health Organization, Geneva, 1999)Google Scholar
  12. 12.
    K.G. Alberti, P. Zimmet, J. Shaw, The metabolic syndrome—a new worldwide definition. Lancet 366(9491), 1059–1062 (2005)PubMedCrossRefGoogle Scholar
  13. 13.
    T.W. Furlanetto, S. Peccin, O.M.A. de Schneider, S.A. dos Zimmer, P.S. dos Reis, S.K. Genro, E.V. Ferreira, F. Bittelbrum, A.S. Muller, R.W. Silva, Siqueira II, M.F. da Silveira, Prevalence of thyroid nodules in 40 years-old or old women. Rev. Assoc. Med. Bras. 46(4), 331–334 (2000)PubMedCrossRefGoogle Scholar
  14. 14.
    S. Ezzat, D.A. Sarti, D.R. Cain, G.D. Braunstein, Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch. Intern. Med. 154(16), 1838–1840 (1994)PubMedCrossRefGoogle Scholar
  15. 15.
    T.V. Bartolotta, M. Midiri, G. Runza, M. Galia, A. Taibbi, L. Damiani, G. Palermo Patera, R. Lagalla, Incidentally discovered thyroid nodules: incidence, and greyscale and colour Doppler pattern in an adult population screened by real-time compound spatial sonography. Radiol. Med. 111(7), 989–998 (2006). doi: 10.1007/s11547-006-0097-1 PubMedCrossRefGoogle Scholar
  16. 16.
    L. Hegedus, H. Perrild, L.R. Poulsen, J.R. Andersen, B. Holm, P. Schnohr, G. Jensen, J.M. Hansen, The determination of thyroid volume by ultrasound and its relationship to body weight, age, and sex in normal subjects. J. Clin. Endocrinol. Metab. 56(2), 260–263 (1983)PubMedCrossRefGoogle Scholar
  17. 17.
    S.A. Ivarsson, P.H. Persson, U.B. Ericsson, Thyroid gland volume as measured by ultrasonography in healthy children and adolescents in a non-iodine deficient area. Acta Paediatr. Scand. 78(4), 633–634 (1989)PubMedCrossRefGoogle Scholar
  18. 18.
    S. Semiz, U. Senol, Bircan, S. Gumuslu, S. Bilmen, I. Bircan, Correlation between age, body size and thyroid volume in an endemic area. J. Endocrinol. Invest. 24(8), 559–563 (2001)PubMedGoogle Scholar
  19. 19.
    H.F. Zhu, Y. Yang, J.Y. Li, X.M. Li, A.G. Ma, Prevalence of thyroid nodules and influencing factors among employees of a company in Qingdao. Zhonghua Yu Fang Yi Xue Za Zhi 46(3), 228–232 (2012)PubMedGoogle Scholar
  20. 20.
    O. Topaloglu, F. Gokay, K. Kucukler, F.S. Burnik, T. Mete, H.C. Yavuz, D. Berker, S. Guler, Is autoimmune thyroiditis a risk factor for early atherosclerosis in premenopausal women even if in euthyroid status? Endocrine (2012). doi: 10.1007/s12020-012-9842-5 PubMedGoogle Scholar
  21. 21.
    J. Rezzonico, M. Rezzonico, E. Pusiol, F. Pitoia, H. Niepomniszcze, Metformin treatment for small benign thyroid nodules in patients with insulin resistance. Metab. Syndr. Relat. Disord. 9(1), 69–75 (2011). doi: 10.1089/met.2010.0026 PubMedCrossRefGoogle Scholar
  22. 22.
    M.L. Isidro, M.A. Penin, R. Nemina, F. Cordido, Metformin reduces thyrotropin levels in obese, diabetic women with primary hypothyroidism on thyroxine replacement therapy. Endocrine 32(1), 79–82 (2007). doi: 10.1007/s12020-007-9012-3 PubMedCrossRefGoogle Scholar
  23. 23.
    V. Vella, L. Sciacca, G. Pandini, R. Mineo, S. Squatrito, R. Vigneri, A. Belfiore, The IGF system in thyroid cancer: new concepts. Mol. Pathol. 54(3), 121–124 (2001)PubMedCentralPubMedCrossRefGoogle Scholar
  24. 24.
    J.N. Rezzonico, M. Rezzonico, E. Pusiol, F. Pitoia, H. Niepomniszcze, Increased prevalence of insulin resistance in patients with differentiated thyroid carcinoma. Metab. Syndr. Relat. Disord. 7(4), 375–380 (2009). doi: 10.1089/met.2008.0062 PubMedCrossRefGoogle Scholar
  25. 25.
    R. Malaguarnera, A. Morcavallo, A. Belfiore, The insulin and igf-I pathway in endocrine glands carcinogenesis. J. Oncol. 2012, 635614 (2012). doi: 10.1155/2012/635614 PubMedCentralPubMedCrossRefGoogle Scholar
  26. 26.
    R. Malaguarnera, F. Frasca, A. Garozzo, F. Giani, G. Pandini, V. Vella, R. Vigneri, A. Belfiore, Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid. J. Clin. Endocrinol. Metab. 96(3), 766–774 (2011). doi: 10.1210/jc.2010-1255 PubMedCrossRefGoogle Scholar
  27. 27.
    G. Rojo-Martinez, I. Esteva, S.R. de Adana, M. Catala, M.J. Merelo, F. Tinahones, J.M. Gomez-Zumaquero, A.L. Cuesta, F. Cardona, F. Soriguer, Patterns of insulin resistance in the general population of southeast Spain. Diabetes Res. Clin. Pract. 65(3), 247–256 (2004). doi: 10.1016/j.diabres.2004.01.004 PubMedCrossRefGoogle Scholar
  28. 28.
    S.E. Kahn, The importance of the beta-cell in the pathogenesis of type 2 diabetes mellitus. Am. J. Med. 108(Suppl 6a), 2S–8S (2000)PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Hongwei Guo
    • 1
  • Min Sun
    • 1
  • Wei He
    • 1
  • Huanhuan Chen
    • 1
  • Wen Li
    • 1
  • Jinmei Tang
    • 1
  • Wei Tang
    • 1
  • Jieli Lu
    • 2
  • Yufang Bi
    • 2
  • Guang Ning
    • 2
  • Tao Yang
    • 1
  • Yu Duan
    • 1
  1. 1.Department of EndocrinologyFirst Affiliated Hospital of Nanjing Medical UniversityNanjingChina
  2. 2.Department of EndocrinologyRuijin Hospital, Medical School of Shanghai Jiaotong UniversityShanghaiChina

Personalised recommendations